Capital Research Global Investors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$167M Sell
1,408,597
-20,552
-1% -$2.54M 0.03% 262
2025
Q4
$180M Buy
1,429,149
+6,503
+0.5% +$848K 0.03% 235
2025
Q3
$208M Buy
1,422,646
+4,707
+0.3% +$711K 0.04% 215
2025
Q2
$221M Buy
1,417,939
+3,231
+0.2% +$512K 0.04% 212
2025
Q1
$233M Buy
1,414,708
+317,994
+29% +$52.9M 0.05% 205
2024
Q4
$179M Buy
+1,096,714
New +$196M 0.04% 235
2024
Q3
Sell
-1,948,733
Closed -$338M 446
2024
Q2
$338M Sell
1,948,733
-2,101,948
-52% -$350M 0.07% 163
2024
Q1
$685M Buy
4,050,681
+90,330
+2% +$16.9M 0.16% 125
2023
Q4
$782M Sell
3,960,351
-147,109
-4% -$26M 0.19% 118
2023
Q3
$715M Sell
4,107,460
-70,325
-2% -$12.8M 0.2% 113
2023
Q2
$719M Sell
4,177,785
-26,074
-0.6% -$4.51M 0.19% 115
2023
Q1
$700M Buy
4,203,859
+303,796
+8% +$49.8M 0.2% 108
2022
Q4
$572M Buy
3,900,063
+581,411
+18% +$86M 0.17% 123
2022
Q3
$492M Buy
3,318,652
+686
+0% +$115K 0.16% 129
2022
Q2
$570M Buy
3,317,966
+1,394
+0% +$241K 0.18% 114
2022
Q1
$625M Sell
3,316,572
-1,497,105
-31% -$296M 0.15% 128
2021
Q4
$1.17B Buy
4,813,677
+1,258
+0% +$276K 0.26% 90
2021
Q3
$934M Sell
4,812,419
-1,489
-0% -$300K 0.22% 105
2021
Q2
$897M Sell
4,813,908
-143,050
-3% -$24.8M 0.21% 111
2021
Q1
$781M Buy
4,956,958
+215,381
+5% +$34.1M 0.19% 125
2020
Q4
$785M Buy
4,741,577
+31,239
+0.7% +$5.08M 0.2% 113
2020
Q3
$779M Buy
4,710,338
+269,743
+6% +$41.5M 0.23% 99
2020
Q2
$609M Buy
4,440,595
+813,255
+22% +$106M 0.19% 115
2020
Q1
$427M Buy
3,627,340
+1,444,228
+66% +$190M 0.17% 119
2019
Q4
$289M Buy
+2,183,112
New +$271M 0.09% 183
2013
Q3
Sell
-1,000,000
Closed -$30.9M 456
2013
Q2
$30.9M Buy
+1,000,000
New +$32.4M 0.01% 359

Other funds holding ZTS

Capital Research Global Investors's ZTS Position: Q1 2026 in Review

Capital Research Global Investors reduced its Zoetis (ZTS) stake by 1.4% in Q1 2026, selling an estimated $2.54M and leaving 1,408,597 shares worth $167M. The position accounts for 0.03% of the portfolio, ranked #262.

Capital Research Global Investors first reported a position in ZTS in Q2 2013 and has held it in 26 quarters since. The position peaked at $1.17B in Q4 2021. 1,611 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Capital Research Global Investors held 1,408,597 shares of Zoetis worth $167M as of Q1 2026.
  • Capital Research Global Investors sold 20,552 Zoetis shares in Q1 2026, an estimated $2.54M.
  • Zoetis made up 0.03% of Capital Research Global Investors's portfolio in Q1 2026, its #262 holding.
  • Capital Research Global Investors first reported a position in Zoetis in Q2 2013 and has held it in 26 quarters since.
  • Capital Research Global Investors's Zoetis position peaked at $1.17B in Q4 2021.
  • 1,611 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.